Cotempla XR-ODT (Neos Therapeutics, LP)


Welcome to the PulseAid listing for the Cotempla XR-ODT drug offered from Neos Therapeutics, LP. This Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Neos Therapeutics, LP
NON-PROPRIETARY NAME: Methylphenidate
SUBSTANCE NAME: METHYLPHENIDATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE]
ROUTE: ORAL
DOSAGE FORM: TABLET, ORALLY DISINTEGRATING
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2016-06-20
END MARKETING DATE: 0000-00-00


Cotempla XR-ODT HUMAN PRESCRIPTION DRUG Details:

Item DescriptionCotempla XR-ODT from Neos Therapeutics, LP
LABELER NAME: Neos Therapeutics, LP
DEA SCHEDULE: CII
ACTIVE STRENGTH: 8.6(mg/1)
START MARKETING DATE: 2016-06-20
END MARKETING DATE: 0000-00-00
PRODUCT ID: 70165-100_8dfc75eb-b2cc-4187-8205-76f0e9a52a8b
PRODUCT NDC: 70165-100
APPLICATION NUMBER: NDA205489

Other METHYLPHENIDATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Neos Therapeutics, LPCotempla XR-ODT
Noven Therapeutics, LLCDaytrana